Citation 99439

STERMITZ,FR: GILLESPIE,JP: AMOROS,LG: ROMERO,R: STERMITZ,TA: LARSON,KA: EARL,S: OGG,JE:. (1975). SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME ANTITUMOR BENZOPHENANTHRIDINIUM SALTS.. 18()

Citation Details

Title	SYNTHESIS AND BIOLOGICAL ACTIVITY OF SOME ANTITUMOR BENZOPHENANTHRIDINIUM SALTS.
Authors	STERMITZ,FR: GILLESPIE,JP: AMOROS,LG: ROMERO,R: STERMITZ,TA: LARSON,KA: EARL,S: OGG,JE:
Year	1975
Volume	18
Issue

Summary

Year: 1975

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FAGARONINE	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FAGARONINE	ACTIVE
3	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FAGARONINE	ACTIVE
4	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FAGARONINE	ACTIVE
5	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	FAGARONINE	ACTIVE
6	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NITIDINE	INACTIVE
7	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	NITIDINE	INACTIVE
8	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY:*	INACTIVE
9	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY:*	INACTIVE
10	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY:*	INACTIVE
11	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	INACTIVE
12	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	INACTIVE
13	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	INACTIVE
14	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	INACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	ACTIVE
16	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-DIMETHOXY:*	INACTIVE
17	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	INACTIVE
18	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	WEAK ACTIVITY
19	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	INACTIVE
20	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	INACTIVE
21	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	ACTIVE
22	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	INACTIVE
23	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	ACTIVE
24	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY:*	ACTIVE
25	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY:*	INACTIVE
26	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY:*	INACTIVE
27	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY:*	INACTIVE
28	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY:*	INACTIVE
29	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-3-O-BENZYL:	INACTIVE
30	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-8-9-DIMETHOXY:	INACTIVE
31	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-8-9-DIMETHOXY:	INACTIVE
32	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
33	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
34	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
35	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
36	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
37	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-9-TETRAMETHOXY:*	ACTIVE
38	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY-9-ETHOXY:*	INACTIVE
39	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY-9-ETHOXY:*	INACTIVE
40	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY-9-ETHOXY:*	ACTIVE
41	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY-9-ETHOXY:*	ACTIVE
42	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY-8-ETHOXY:*	WEAK ACTIVITY
43	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY-8-ETHOXY:*	ACTIVE
44	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY-8-ETHOXY:*	INACTIVE
45	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY-8-ETHOXY:*	INACTIVE
46	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	INACTIVE
47	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	INACTIVE
48	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	WEAK ACTIVITY
49	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	INACTIVE
50	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	ACTIVE
51	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-9-DIMETHOXY-2-3-DIETHOXY:*	ACTIVE
52	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-8-9-TRIMETHOXY-2-ISO-PROPOXY:*	INACTIVE
53	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-8-9-TRIMETHOXY-2-ISO-PROPOXY:*	ACTIVE
54	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-8-9-TRIMETHOXY-2-ISO-PROPOXY:*	INACTIVE
55	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-8-9-TRIMETHOXY-3-ISO-PROPOXY:*	ACTIVE
56	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-8-9-TRIMETHOXY-3-ISO-PROPOXY:*	ACTIVE
57	Not specified	COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-9-TRIMETHOXY-8-ISO-PROPOXY:*	None
58	Not specified	COMPLETE SYNTHESIS REPORTEDANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-2-3-8-TRIMETHOXY-9-ISO-PROPOXY:*	None
59	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	INACTIVE
60	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	INACTIVE
61	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
62	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
63	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
64	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
65	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
66	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
67	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-3-HYDROXY-2-8-9-TRIMETHOXY:*	ACTIVE
68	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
69	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
70	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
71	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
72	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
73	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-8-HYDROXY-2-3-9-TRIMETHOXY:*	INACTIVE
74	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
75	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
76	ANTITUMOR ACTIVITY	COMPLETE SYNTHESIS REPORTEDPHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
77	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
78	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
79	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	BENZO-(C)-PHENANTHRIDIUM,5-METHYL-9-HYDROXY-2-3-8-TRIMETHOXY:*	INACTIVE
80	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANGUINARINE	ACTIVE
81	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	SANGUINARINE	ACTIVE
82	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHELERYTHRINE	ACTIVE
83	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)ANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CHELERYTHRINE	ACTIVE

Citation 99439

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1